Stay updated with breaking news from Masimo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vital Signs Monitoring Market to Witness Rebound Sales in the Upcoming Years, the Market to Worth $33.36 Billion by 2028 - Arizton
By Denny Jacob Masimo Corp. said Monday it plans to lower its full-year revenue guidance as revenue for the second quarter is expected to come in below its...
Masimo Co. (NASDAQ:MASI – Free Report) has been given an average recommendation of “Moderate Buy” by the eight research firms that are currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 12 month price objective […]
Politan Capital won two seats on the board of monitoring-tech firm Masimo. Carlyle Group cut its stake in pharmaceuticals firm Vera.
Masimo (NASDAQ:MASI – Free Report) and Nexalin Technology (NASDAQ:NXL – Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, institutional ownership, earnings, profitability, risk and analyst recommendations. Profitability This table compares Masimo and Nexalin Technology’s net margins, return […]